Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat the highly contagious stomach virus.

Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.

Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

A surge in respiratory illness is typical for this time of year, and the simultaneous outbreak of highly contagious norovirus is piling on to the public health risk. Commonly known as stomach flu, ...

The number of bird flu cases in Central Massachusetts is relatively low, compared to a swath of the state that runs from ...

Kansas City faces one of the worst U.S. tuberculosis outbreaks, with 67 active cases and 384 people under monitoring.

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Sneezing, fever, chills, vomiting, coughing — it’s not just one virus wreaking havoc this winter; it’s a combination of four ...

Concerns about bird flu are growing among health officials weeks after the first person in the U.S. died from the virus, and ...

As more cases of bird flu emerge across the country, public health leaders in New York City are watching warily -- and making ...

Hospitalizations and general "syndromic" cases were at 10+ statewide for the week. The number of reported COVID cases ...